PubRank

J L Cleveland

Author PubWeight™ 137.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998 9.03
2 Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999 6.87
3 Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991 5.32
4 The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 1993 4.66
5 Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000 3.72
6 Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000 3.06
7 Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci U S A 1993 2.88
8 Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 1986 2.64
9 p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene 1992 2.49
10 Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 1992 2.41
11 Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 1990 2.24
12 Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 2001 2.15
13 Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol 2001 1.96
14 Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995 1.85
15 Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature 1991 1.83
16 Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 1991 1.82
17 Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A 1997 1.82
18 Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol 1999 1.80
19 c-Myc and apoptosis. Biochim Biophys Acta 1995 1.80
20 Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature 1985 1.77
21 Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999 1.71
22 The Max network gone mad. Mol Cell Biol 2001 1.66
23 The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001 1.65
24 Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol Cell Biol 1998 1.62
25 Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol Cell Biol 1993 1.62
26 Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med 1995 1.59
27 raf family serine/threonine protein kinases in mitogen signal transduction. Cold Spring Harb Symp Quant Biol 1988 1.57
28 Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem 1992 1.56
29 Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 1994 1.55
30 Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J 1997 1.49
31 Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev 2000 1.47
32 Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 2000 1.42
33 Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 1994 1.40
34 Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene 1990 1.40
35 Role of myc in the abrogation of IL3 dependence of myeloid FDC-P1 cells. Oncogene Res 1987 1.38
36 A pathway distinct from the mammalian unfolded protein response regulates expression of endoplasmic reticulum chaperones in non-stressed cells. EMBO J 1997 1.38
37 Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus. J Virol 1985 1.35
38 Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis 2001 1.30
39 Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 2001 1.25
40 Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 1998 1.24
41 E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol 1995 1.20
42 PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. Oncogene 1992 1.19
43 Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood 1991 1.18
44 Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro. J Cell Biochem 1986 1.16
45 Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev 1998 1.15
46 Percutaneous injuries during oral and maxillofacial surgery procedures. J Oral Maxillofac Surg 1997 1.13
47 Insertion and truncation of c-myb by murine leukemia virus in a myeloid cell line derived from cultures of normal hematopoietic cells. J Virol 1987 1.13
48 Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 1994 1.11
49 E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol 1997 1.09
50 Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human. Proc Natl Acad Sci U S A 1986 1.09
51 Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice. Proc Natl Acad Sci U S A 1986 1.08
52 c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 1996 1.05
53 Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 1993 1.04
54 Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood 2001 1.02
55 E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ 1998 1.02
56 Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol 1998 1.01
57 Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol 1992 0.96
58 Position and orientation independent transactivation by c-Myc. Cell Mol Biol Res 1994 0.95
59 Occupational blood exposure and HIV infection among oral and maxillofacial surgeons. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 0.95
60 Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. J Immunol 1987 0.95
61 Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene 1997 0.94
62 Interleukin 3 (IL-3) induces transcription from nonrearranged T cell receptor gamma loci in IL-3-dependent cell lines. J Exp Med 1989 0.94
63 Transformation of murine bone marrow cells with combined v-raf-v-myc oncogenes yields clonally related mature B cells and macrophages. Mol Cell Biol 1990 0.94
64 Biochemical and molecular events associated with interleukin 2 regulation of lymphocyte proliferation. Immunol Rev 1986 0.93
65 Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol Cell Biol 2001 0.92
66 E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001 0.92
67 Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants. J Immunol 1987 0.92
68 c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. J Biol Chem 2001 0.91
69 The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Res 1999 0.90
70 Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 1993 0.88
71 The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr Top Microbiol Immunol 1995 0.88
72 c-myc transactivates the ornithine decarboxylase gene. Curr Top Microbiol Immunol 1992 0.87
73 Cytokines suppress apoptosis independent of increases in reactive oxygen levels. J Immunol 1996 0.87
74 Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alpha. Cell Death Differ 1997 0.86
75 v-Raf/v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. Curr Top Microbiol Immunol 1992 0.84
76 Oncogenes: clinical relevance. Haematol Blood Transfus 1987 0.83
77 Cancer. A radical approach to treatment. Nature 2000 0.82
78 Transformation by raf and myc oncogenes. Princess Takamatsu Symp 1986 0.82
79 Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. Blood 2001 0.81
80 Serum suppresses myeloid progenitor apoptosis by regulating iron homeostasis. J Cell Biochem 2001 0.81
81 The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences. Oncogene 1995 0.81
82 Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene 1995 0.80
83 EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Curr Top Microbiol Immunol 2001 0.80
84 A role for c-myc in chemically induced renal-cell death. Mol Cell Biol 1997 0.80
85 In vitro transformation of murine bone marrow cells with a v-raf/v-myc retrovirus yields clonally related mature B cells and macrophages. Curr Top Microbiol Immunol 1988 0.79
86 Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells. Biochem Pharmacol 2001 0.79
87 Tumors of newborn NFS/N mice infected with murine retroviruses containing avian v-myc. Curr Top Microbiol Immunol 1986 0.79
88 Percutaneous exposures to HIV-infected blood. Among dental workers enrolled in the CDC Needlestick Study. J Am Dent Assoc 1995 0.78
89 Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis. Oncogene 2006 0.76
90 Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma. Med Pediatr Oncol 2001 0.76
91 Cast production: accurate, simple and economic. J Ir Dent Assoc 1977 0.75
92 Lower glycemic response to sucrose in the diets of children with type 1 diabetes. J Pediatr 1998 0.75
93 Transformation and insertional mutagenesis in vitro of primary hematopoietic stem cell cultures. Curr Top Microbiol Immunol 1986 0.75
94 Metal shell temporization: effective and protective. Dent Surv 1977 0.75
95 Mechanisms in interleukin 3 regulated growth and differentiation. Adv Exp Med Biol 1987 0.75
96 Custom shading for temporary-coverage restorations. J Prosthet Dent 1974 0.75
97 Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP. J Immunol 1988 0.75
98 Polycarbonate resin and its use in the matrix technique for temporary coverage. J Prosthet Dent 1973 0.75
99 Tender loving care for crown and bridge. S C Dent J 1978 0.75
100 Structural and functional analysis of the promoter of the murine V gamma 1.1 T cell receptor gene. Eur J Immunol 1995 0.75
101 Abrogation of IL-3 dependence of myeloid FDC-P1 cells by tyrosine kinase oncogenes is associated with induction of c-myc. Curr Top Microbiol Immunol 1988 0.75
102 Similar glycemic responses to high versus moderate sucrose-containing foods in test meals for adolescents with type 1 diabetes and fasting euglycemia. J Am Diet Assoc 2001 0.75
103 Chairside preventive teaching with crown and bridge. J Acad Gen Dent 1975 0.75
104 Surface characterization of temporary restorations: guidelines for quality ceramics. J Prosthet Dent 1977 0.75
105 Regulation of T cell receptor gamma gene expression by cytokines in murine hematopoietic cells. Eur Cytokine Netw 1995 0.75